Here, we have retrospectively analyzed PDL1 mRNA expression in 112 IBC profiled using DNA microarrays to determine its prevalence and to search for correlations with histo-clinical features, including response to chemotherapy and survival. This evidence concerns the gene CD274 and inflammatory breast carcinoma.